SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

Viruses, Free Full-Text

SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern - eBioMedicine

Biology, Free Full-Text

Conformational Behavior of SARS-Cov-2 Spike Protein Variants: Evolutionary Jumps in Sequence Reverberate in Structural Dynamic Differences

A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress Response to Reactive Oxygen Species

Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron

Frontiers Adaptive Immune Responses and Immunity to SARS-CoV-2

Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies - ScienceDirect

Viruses, Free Full-Text

The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages - ScienceDirect

What to Know About EG.5 (Eris)—the Latest Coronavirus Strain > News > Yale Medicine

Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants